Canada Approves First Sleep Apnea Drug for Obesity Patients

Canadians living with obesity and sleep apnea now have a new treatment option that tackles both conditions at once.

Health Canada just approved Zepbound, a medication that helps patients lose weight while reducing dangerous breathing interruptions during sleep.